By Anonymous (not verified), 1 April, 2026 A leadership transition aligned with our growth journey - Saharsh Davuluri assumes charge as CEO & Managing Director, Neuland Labs
By Anonymous (not verified), 1 April, 2026 Saharsh Davuluri takes over as CEO & MD of Neuland and will lead the next phase of CDMO expansion
By Anonymous (not verified), 28 March, 2026 Why Peptide API Projects Are Delayed at Regulatory Review and How to Avoid It
By Anonymous (not verified), 1 March, 2026 Dual Sourcing in CDMO Partnerships: A Strategic Framework for Resilient Drug Supply
By Anonymous (not verified), 1 March, 2026 How CDMO Partnerships Improve R&D ROI for Biopharma Companies
By Anonymous (not verified), 28 February, 2026 Understanding CDMO Regulatory Support for Global Filings
By Anonymous (not verified), 3 February, 2026 From IND to Commercial: How Neuland Ensures Phase-Appropriate Development
By Anonymous (not verified), 3 February, 2026 What Is API Process Development? Key Steps and Best Practices